Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial

AIMS: We investigated clinical characteristics and outcomes of patients with significant valvular disease (SVD) in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) trial. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Breithardt, Günter, Baumgartner, Helmut, Berkowitz, Scott D., Hellkamp, Anne S., Piccini, Jonathan P., Stevens, Susanna R., Lokhnygina, Yuliya, Patel, Manesh R., Halperin, Jonathan L., Singer, Daniel E., Hankey, Graeme J., Hacke, Werner, Becker, Richard C., Nessel, Christopher C., Mahaffey, Kenneth W., Fox, Keith A. A., Califf, Robert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265383/
https://www.ncbi.nlm.nih.gov/pubmed/25148838
http://dx.doi.org/10.1093/eurheartj/ehu305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265383/
https://www.ncbi.nlm.nih.gov/pubmed/25148838
http://dx.doi.org/10.1093/eurheartj/ehu305

Ejemplares similares